X

Trial Profile

Phase I trial of RG 7652 in healthy subjects with elevated LDL-cholesterol levels.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 30 Mar 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RG 7652 (Primary) ; Atorvastatin
Indications Hypercholesterolaemia
Focus Biomarker; First in man; Pharmacodynamics
Sponsors Genentech; Roche

Most Recent Events

22 Mar 2017 Results published in the Clinical Cardiology
20 Nov 2013 Results reporting effects of treatment on lipid and inflammatory biomarkers presented at the 86th Annual Scientific Sessions of the American Heart Association.
04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com